ICHG 2011

Recent articles

Spectrum from The Transmitter.

Growth factor improves autism symptoms in mice

Mice lacking a copy of SHANK3, a gene associated with autism and intellectual disability, show marked improvements in brain signaling after being treated with insulin-like growth factor 1, according to unpublished findings presented Saturday at the International Congress of Human Genetics in Montreal, Canada.

By Deborah Rudacille
19 October 2011 | 5 min read
Spectrum from The Transmitter.

Researchers debut mice with links to Williams syndrome

Mouse pups with a duplication of GTF2I, a gene linked to Williams syndrome and autism, show extreme separation anxiety when separated from their mothers, according to unpublished findings presented Thursday at the International Congress of Human Genetics in Montreal, Canada.

By Deborah Rudacille
17 October 2011 | 5 min read
Spectrum from The Transmitter.

Fast-evolving gene is key player in brain development

A gene that changed rapidly after the human genome diverged from that of Neanderthals plays a critical role in brain development, according to unpublished results presented Thursday at the International Congress of Human Genetics in Montreal, Canada.

By Deborah Rudacille
14 October 2011 | 4 min read

Explore more from The Transmitter

Stack of papers.

Exclusive: The 23 studies the FDA based its expanded leucovorin label on

The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.

By Claudia López Lloreda
2 October 2025 | 6 min read
Hand holding a rubber stamp above a stack of papers.

Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns

An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.

By Calli McMurray
2 October 2025 | 10 min read
Richard Frye.

Exclusive: Who is Richard Frye, the neurologist who researches and advocates for leucovorin as an autism treatment?

Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.

By Brendan Borrell
1 October 2025 | 11 min read

privacy consent banner

Privacy Preference

We use cookies to provide you with the best online experience. By clicking “Accept All,” you help us understand how our site is used and enhance its performance. You can change your choice at any time. To learn more, please visit our Privacy Policy.